William Blair News
-
-
-
-
-
ProfitSolv Has Received a Significant Strategic Investment Co-Led by FTV Capital and Existing Investor Lightyear Capital
William Blair acted as financial advisor to ProfitSolv, a portfolio company of Lightyear Capital, in connection with their significant strategic investment co-led by FTV Capital and existing investor Lightyear Capital.
-
-
-
Contineum Therapeutics, Inc.: Initiation of Research Coverage
William Blair initiated research coverage of Contineum Therapeutics, Inc. (CTNM $3.93), a clinical-stage biotech developing small-molecule therapeutics for high-unmet-need indications in the prevalent neuroinflammation and immunology space.
-
-
-
-
-
Hinge Health, Inc.: Initiation of Research Coverage
William Blair initiated research coverage of Hinge Health, Inc. (HNGE $35.02), a digital health organization that is leveraging technology to automate care delivery, initially focused on a broad spectrum of musculoskeletal (MSK) care needs for acute, chronic, and postsurgical rehabilitation.
-
-
-
-
-
Brightflag Has Agreed to Be Acquired by Wolters Kluwer
William Blair acted as exclusive financial advisor to Brightflag, a portfolio company of One Peak Partners, Sands Capital, Frontline Ventures, Tribal Ventures, and Enterprise Ireland, in connection with its pending sale to Wolters Kluwer (EURONEXT: WKL) for €425 million.
-
William Blair Continues Private Capital Advisory Growth in Europe With Senior Hire
William Blair, the premier global partnership with expertise in investment banking, investment management, and private wealth management, announced today the continued growth of the firm’s Private Capital Advisory team in Europe with the addition of industry veteran Delaney Brown.
-
-
Ultragenyx Pharmaceutical Inc.: Initiation of Research Coverage
William Blair initiated research coverage of Ultragenyx Pharmaceutical Inc. (RARE $35.66), a commercial-stage, modality-agnostic biotechnology company specializing in developing therapies for the treatment of rare and ultrarare genetic diseases.
-
-
Astera Labs, Inc.: Initiation of Research Coverage
William Blair initiated research coverage of Astera Labs, Inc. (ALAB $94.46), a provider of semiconductor solutions for PCIe and Ethernet connectivity use-cases, across a multiproduct portfolio that includes Aries, Tauris, Leo, and Scorpio product lines.
-
-
Primutec Solutions Group Has Agreed to be Acquired by Trill Impact
William Blair acted as the exclusive financial advisor to Primutec Solutions Group B.V., owned by Funds advised by DPE Deutsche Private Equity Management and management, in connection with its pending sale to Funds managed by Trill Impact.
-
-
-
-
-
-
-
-
-
William Blair Initiates Coverage of Two Companies Developing Retinal Disease Therapies
William Blair initiated research coverage of Kalaris Therapeutics, Inc. (KLRS $7.08) and Ocular Therapeutix, Inc. (OCUL $6.36), both biotechnology companies developing therapies for the treatment of retinal vascular diseases.
-
-
-
-
-
-
-
-
-
-
-
-
Karman Holdings Inc.: Initiation of Research Coverage
William Blair initiated research coverage of Karman Holdings Inc. (KRMN $28.16), a leading merchant supplier to the U.S. missile, drone, and space industries with a key role in over 100 strategic programs. Karman made its debut on the NYSE on February 13.
-
William Blair Initiates Coverage of Seven Companies in the Obesity Treatment Space
William Blair initiated research coverage of Altimmune, Inc. (ALT $5.91), BioAge Labs, Inc. (BIOA $4.18), Corbus Pharmaceuticals Holdings, Inc. (CRBP $7.50), Skye Bioscience, Inc. (SKYE $2.89), Structure Therapeutics, Inc. (GPCR $21.09), Terns Pharmaceuticals, Inc. (TERN $3.71), and Zealand Pharma A/S (ZEAL-CSE DKK 719.00).
-
-
-
-
-
-
-
Rubrik, Inc.: Initiation of Research Coverage
William Blair initiated research coverage of Rubrik, Inc. (RBRK $75.59), a leading vendor in the fast-evolving data protection (DP) industry, pioneering a next-generation approach to data backup and transforming perceptions of DP technology from “boring old backup” to a must-have cyber resilience platform.
-
Mersana Therapeutics, Inc.: Initiation of Research Coverage
William Blair initiated research coverage of Mersana Therapeutics, Inc. (MRSN $0.57), whose lead program emiltatug ledadotin is an ADC that targets B7-H4; it is in Phase I development for TNBC. The company is also developing a HER2-targeted immune-stimulating ADC, XMT-2056, in a Phase I solid tumor study.
-
-
-
smaXtec Has Agreed to be Acquired by KKR Growth and Highland Europe
William Blair acted as exclusive financial advisor to smaXtec, the world’s leading provider of bolus technology for the dairy industry and AI-powered dairy health management software, in connection with its pending sale to KKR Growth and Highland Europe.
-
Sterling Infrastructure, Inc.: Initiation of Research Coverage
William Blair initiated research coverage of Sterling Infrastructure, Inc. (STRL $177.15), which provides site development and construction services for the data center, e-commerce, semiconductor, transportation, and residential end-markets.
-
William Blair Advises Genstar Capital on Strategic Majority Investment in Aperture
William Blair acted as the financial advisor to Genstar Capital, a leading private equity firm, in connection with its strategic majority investment in Aperture, LLC, a national platform of best-in-class forensic experts and portfolio company of Trinity Hunt Partners.
-
-
-
William Blair Advises GRAM as it Partners with UniVista Insurance to Drive Next Chapter of Growth
William Blair acted as the exclusive financial advisor to GRAM’s Americas Buyout Fund, the private equity division of GRAM, in connection with its majority investment in UniVista Insurance, a leading distributor of insurance products and services to Hispanic communities in Florida and Texas.
-
William Blair Expands Biopharma Investment Banking Group With Senior Hire
William Blair, the premier global boutique with expertise in investment banking, investment management, and private wealth management, today announced the addition of Terence Tan as managing director in the firm’s Healthcare investment banking team.
-
-
Cboe Global Markets, Inc.: Initiation of Research Coverage
William Blair initiated research coverage of Cboe Global Markets, Inc. (CBOE $190.84), a leading derivatives and securities exchange network that provides trading, clearing, data, and technology solutions to a broad range of market participants globally.
-
-
-
-
ServiceTitan, Inc.: Initiation of Research Coverage
William Blair initiated research coverage of ServiceTitan, Inc. (TTAN $101.50), which offers a leading end-to-end business management software platform for the trades industry, powering core operations for residential and commercial services businesses in areas such as HVAC, electrical, and plumbing.
-
Elevation Oncology, Inc.: Initiation of Research Coverage
William Blair initiated research coverage of Elevation Oncology, Inc. (ELEV $0.56), a clinical-stage biotechnology company advancing a Phase I antibody-drug conjugate (ADC) against claudin 18.2, initially targeting gastric cancer/gastroesophageal junction (GEJ) adenocarcinoma with pancreatic cancer as an expansion opportunity.
-
Denali Therapeutics Inc.: Initiation of Research Coverage
William Blair initiated research coverage of Denali Therapeutics Inc. (DNLI $20.38), a clinical-stage biotechnology company developing treatments for CNS and other indications by leveraging its unique blood–brain barrier penetrating technology platform.
-
-
Vigil Neuroscience, Inc.: Initiation of Research Coverage
William Blair initiated research coverage of Vigil Neuroscience, Inc. (VIGL $2.47), a clinical-stage biopharma focused on developing microglial-targeting therapeutics by leveraging genetic insights into degenerative disorders of the central nervous system (CNS).
-
-
-
-
Nasdaq, Inc.: Initiation of Research Coverage
William Blair initiated research coverage of Nasdaq, Inc. (NDAQ $80.88), a leading global technology company with a broad range of offerings, including equities and options exchanges, data, investment analytics, software, marketplace technology, and corporate solutions.
-
-
-
-
-
-
-
-
-
-
CeriBell, Inc.: Initiation of Research Coverage
William Blair initiated research coverage of CeriBell, Inc. (CBLL $26.42). The Ceribell ecosystem is an AI-powered point-of-care electroencephalography (EEG) device used in the detection of seizures and other neurological conditions in the acute-care setting.
-
CAMP4 Therapeutics, Inc.: Initiation of Research Coverage
William Blair initiated research coverage of CAMP4 Therapeutics, Inc. (CAMP $10.05). Camp4 is pioneering therapies for rare diseases by harnessing recently discovered regulatory RNA (regRNA) to modulate epigenetic expression of genetic targets.
-
-
-
-
-
-
-
-
-
William Blair Expands Private Capital Advisory Group in Europe
William Blair, the premier global boutique with expertise in investment banking, investment management, and private wealth management, announced today the expansion of the firm’s Private Capital Advisory team in Europe with the addition of Connor O’Keeffe as managing director. Based in London, O’Keeffe will focus on fund placement and advisory services for general partners (GPs) throughout Europe.
-
William Blair Initiates Coverage of Three Leading Waste and Recycling Companies
William Blair initiated research coverage of Casella Waste Systems, Inc. (CWST $98.52), Republic Services, Inc. (RSG $201.28), and Waste Management, Inc. (WM $207.93), leading providers of solid waste and recycling solutions.
-
Tenax Therapeutics, Inc.: Initiation of Research Coverage
William Blair initiated research coverage of Tenax Therapeutics, Inc. (TENX $3.45). Tenax is focused on pulmonary and cardiovascular diseases, including lead program levosimendan for the treatment of pulmonary hypertension in patients with heart failure with preserved ejection fraction (PH-HFpEF).
-
-
William Blair Initiates Coverage of Three Leading Semiconductor Companies
William Blair initiated research coverage of NVIDIA Corporation (NVDA $116.78), Broadcom Inc. (AVGO $164.02), and Arm Holdings plc (ARM $140.14). Nvidia designs accelerated computing chips and hardware systems for AI, gaming, robotics, and autos. Broadcom is a leading designer, developer, and supplier of semiconductor and infrastructure software solutions. Arm is a developer of processor IP that licenses its technology to a broad set of hyperscalers and OEMs.
-
-
-
Shift4 Payments, Inc.: Initiation of Research Coverage
William Blair initiated research coverage of Shift4 Payments, Inc. (FOUR $83.10), a leading merchant acquirer or payment service provider (PSP). Shift4 operates four complementary businesses: a proprietary gateway, a leading venue payments and ticketing business, an emerging software-enabled POS, and a cross-border e-commerce acquirer.
-
Venminder Has Been Acquired by Ncontracts
William Blair served as the exclusive financial advisor to Venminder, a portfolio company of Bain Capital Ventures, Silversmith Capital Partners, MissionOG and other minority investors, in connection with its sale to Ncontracts. Simultaneously with this transaction, Ncontracts was acquired by Hg from Gryphon Investors.
-
-
William Blair Continues Investment Banking Growth With Financial Services Managing Director
William Blair, the premier global boutique with expertise in investment banking, investment management, and private wealth management, today announced the addition of Derek Smith as managing director to the firm’s Financial Services practice in Chicago.
-
-
William Blair Initiates Coverage of Five Companies in the Energy and Sustainability Industry
William Blair initiated research coverage of GE Vernova Inc. (GEV $185.55), Tesla, Inc. (TSLA $209.29), First Solar, Inc. (FSLR $235.42), Enphase Energy, Inc. (ENPH $122.53), and SolarEdge Technologies, Inc. (SEDG $25.69).
-
-
-
-
-
-
AMCS has Agreed to Receive a Majority Investment From EQT Private Equity
William Blair acted as the exclusive financial advisor to AMCS, a portfolio company of Insight Partners, Clearlake, Highland Europe, Ireland Strategic Investment Fund, and Enterprise Ireland, in connection with its pending majority sale to EQT Private Equity.
-
-
M-Files Has Agreed to Receive a Majority Investment Led by Haveli Investments & Bregal Milestone
William Blair acted as exclusive financial advisor to M-Files, the leader in knowledge work automation, in connection with its pending majority recapitalization led by Haveli Investments and Bregal Milestone.
-
Applied Therapeutics, Inc.: Initiation of Research Coverage
William Blair initiated research coverage of Applied Therapeutics, Inc. (APLT $5.04), a development-stage biotechnology company with a pipeline that includes late-stage assets in several rare diseases and some opportunities in larger indications.
-
-
Telix Pharmaceuticals Limited: Initiation of Research Coverage
William Blair initiated research coverage of Telix Pharmaceuticals Limited (TLX-ASX AUD 19.22), a commercial-stage radiopharmaceuticals company that markets Illuccix for imaging prostate cancer and may, pending regulatory approval, also market imaging agents for renal masses and glioblastoma.
-
-
-
-
William Blair Raises Over $2.5B in Non-Control Financings in Q2 2024
Private capital markets have remained extremely active in recent years as company leaders and financial sponsors seek to utilize flexible, non-control capital solutions to generate partial liquidity, accelerate organic and inorganic growth, and optimize their balance sheets.
-
-
Varicent Has Agreed to Receive a Strategic Investment Led by Warburg Pincus
William Blair acted as financial advisor to Varicent, a portfolio company of Great Hill Partners and Spectrum Equity, in connection with its pending strategic investment led by Warburg Pincus, LLC, alongside existing investor Great Hill Partners, with participation from Spectrum Equity and company management.
-
-
LumApps Has Received a Strategic Investment from Bridgepoint
William Blair acted as the exclusive financial advisor to LumApps, a portfolio company of Eurazeo, Goldman Sachs Growth, Bpifrance, and IRIS Capital Group in connection with its strategic investment from Bridgepoint Group in a deal valued at $650 million.
-
-
-
-
-
Waystar Holding Corp.: Initiation of Research Coverage
William Blair initiated research coverage of Waystar Holding Corp. (WAY $21.50), a leading provider of end-to-end revenue cycle management (RCM) software solutions, partnering with hospital systems and ambulatory care providers to drive superior RCM performance from patient financial clearance and price transparency all the way through final cash collections.
-
-
-
-
-
-
William Blair Growth Stock Conference: Caution Around Current Growth, Realistically Constructive About the Future
Explore Macro Analyst Richard de Chazal’s analysis from the 44th annual Growth Stock Conference, highlighting the economy’s vitality, as observed by the presenting companies and investors who attended the conference.
-
Tenaya Therapeutics, Inc.: Initiation of Research Coverage
William Blair initiated research coverage of Tenaya Therapeutics, Inc. (TNYA $3.67), a clinical-stage, modality-agnostic biotech company focused on the development of potentially curative therapies for rare and prevalent cardiovascular diseases.
-
-
-
-
-
-
Federal Signal Corporation: Initiation of Research Coverage
William Blair initiated research coverage of Federal Signal Corporation (FSS $87.25), a manufacturer of specialty commercial vehicles and audio and visual warning equipment for municipal, state, and federal government and industrial end-markets.
-
-
The Brink’s Company: Initiation of Research Coverage
William Blair initiated research coverage of The Brink’s Company (BCO $97.00), a logistics-based cash and valuables management company that spans across more than 100 countries, with solutions for cash-in-transit, ATM services, cash management services, vault outsourcing, money processing, and transportation of high-value goods.
-
William Blair Expands Private Wealth Management Team in Philadelphia With Three Veteran Advisors
William Blair, the premier global boutique with expertise in investment banking, investment management, and private wealth management, announced today the expansion of the firm’s Private Wealth Management presence in Philadelphia with the addition of Fernberger Wealth Management.
-
-
-
-
-
-
Duomed Has Entered Into Exclusive Negotiations to be Acquired by Palex
William Blair acted as the exclusive financial advisor to Duomed Group, a portfolio company of G Square Healthcare Private Equity, in connection with the contemplated sale to Palex Medical, a portfolio company of Apax Partners and Fremman Capital.
-
-
-
-
-
-
Cullinan Oncology, Inc.: Initiation of Research Coverage
William Blair initiated research coverage of Cullinan Oncology, Inc. (CGEM $17.37), a company focused on advancing modality-agnostic targeted therapies for cancer, with a broad pipeline encompassing small molecules and multifunctional therapies across a diverse range of oncologic targets.
-
-
Vital Farms, Inc.: Initiation of Research Coverage
William Blair initiated research coverage of Vital Farms, Inc. (VITL $24.71), an ethically minded food company that is disrupting the U.S. food system. Vital Farms has developed a framework that challenges the norms of the factory food model and allows it to bring high-quality products—namely pasture-raised eggs—from a network of family farms to a national audience.
-
-
-
Pinstripes Holdings, Inc.: Initiation of Research Coverage
William Blair initiated research coverage of Pinstripes Holdings, Inc. (PNST $2.95), a high-volume dining and entertainment brand that combines scratch-made Italian American cuisine with entertainment offerings such as bowling, bocce, and private event spaces.
-
Buyers Edge Platform Has Received a Preferred Equity Investment Led by General Atlantic Credit’s Atlantic Park Fund, Alongside Blackstone Tactical Opportunities and Morgan Stanley Tactical Value
William Blair served as a placement agent to Buyers Edge Platform, a portfolio company of Bregal Sagemount, in connection with its $425 million preferred equity investment led by General Atlantic Credit’s Atlantic Park fund, alongside funds managed by Blackstone Tactical Opportunities and investment funds managed by Morgan Stanley Tactical Value.
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Alto Neuroscience, Inc.: Initiation of Research Coverage
William Blair initiated research coverage of Alto Neuroscience, Inc. (ANRO $13.72), a company focused on developing novel therapies for high-unmet-need indications in psychiatry supported by AI-enabled precision approaches to identify response biomarkers.
-
Keros Therapeutics, Inc.: Initiation of Research Coverage
William Blair initiated research coverage of Keros Therapeutics, Inc. (KROS $59.49), a company focused on the development of novel therapies targeting the TGF-β superfamily of cytokines, which play essential roles in the proliferation and differentiation of numerous cell types.
-
-
-
-
-
-
-
-
-
-
-
Fortrea Holdings Inc.: Initiation of Research Coverage
William Blair initiated research coverage of Fortrea Holdings Inc. (FTRE $33.00), a global clinical research organization (CRO) providing comprehensive Phase I through Phase IV biopharmaceutical product and medical device services, patient access solutions, and other enabling services.
-
-
-
-
-
-
-
-
-
William Blair Initiates Coverage of Three Companies in the Commercial Aviation Industry
William Blair initiated research coverage of three companies, which provide aftermarket parts distribution and maintenance, repair, and overhaul services to aviation customers. These include The Boeing Company (BA $237.33), HEICO Corporation (HEI $177.73), and TransDigm Group Incorporated (TDG $972.96).
-
VistaGen Therapeutics, Inc.: Initiation of Research Coverage
William Blair initiated research coverage of VistaGen Therapeutics, Inc. (VTGN $3.65), a clinical-stage biopharmaceutical company focused on developing next-generation treatment options for social anxiety disorder (SAD) and other neuropsychiatric disorders.
-
-
-
HqO Raises Series D Funding Led by Koch Real Estate Investments
William Blair acted as financial advisor to HqO, Inc., in connection with its over $50 million Series D funding round, led by Koch Real Estate Investments, a subsidiary of Koch Industries, along with participation from existing investors, including Accomplice, Insight Partners, and Related.
-
-
-
-
-
-
-
-
-
-
Celsius Holdings, Inc.: Initiation of Research Coverage
William Blair initiated research coverage of Celsius Holdings, Inc. (CELH $162.02), a high-growth company that develops, processes, markets, sells, and distributes functional energy drinks and liquid supplements in the United States and abroad.
-
-
-
-
-
-
-
RayzeBio, Inc.: Initiation of Research Coverage
William Blair initiated research coverage of RayzeBio, Inc. (RYZB $19.23), a clinical-stage radiopharmaceuticals company with actinium-225-based lead program RYZ101 in a Phase III trial in neuroendocrine tumors (NETs) and Phase Ib study in small-cell lung cancer (SCLC).
-
-
-
-
-
-
-
-
William Blair Initiates Coverage of Three Companies in the Sustainability Services Industry
William Blair initiated research coverage of three companies that provide consulting services in the sustainability services industry. These include NV5 Global, Inc. (NVEE $95.47), ICF International, Inc. (ICFI $129.24), and Tetra Tech, Inc. (TTEK $154.72).
-
-
-
-
-
Economics Weekly: Recession? It’s All About the Lags
In this Economics Weekly, we discuss the recession probability, with the view that since the Fed only started to raise interest rates in March last year, the U.S. is far from being out of the woods just yet, and it is much too soon to be complacent about growth.
-
-
-
-
-
-
-
-
-
-
Consilio Has Agreed to Acquire Lawyers On Demand
William Blair acted as the exclusive financial advisor to Consilio, a portfolio company of Stone Point Capital and Aquiline Capital Partners, in connection with its pending acquisition of Lawyers On Demand (LOD) Group, a portfolio company of Bowmark Capital LLP.
-
-
-
-
-
-
-
-
-
-
-
-
Tarsus Pharmaceuticals, Inc.: Initiation of Research Coverage
William Blair initiated research coverage of Tarsus Pharmaceuticals, Inc. (TARS $17.65), a development-stage biopharmaceutical company focused on therapies that address large market opportunities in ophthalmic conditions with limited treatment options.
-
-
-
-
-
-
-
CAVA Group, Inc.: Initiation of Research Coverage
William Blair initiated research coverage of CAVA Group, Inc. (CAVA $39.20), the category leader in the fast-growing Mediterranean fast-casual restaurant space, with a customizable menu featuring bowls and pitas enhanced by a proprietary line of flavorful dips and spreads.
-
Ferguson plc: Initiation of Research Coverage
William Blair initiated research coverage of Ferguson plc (FERG $156.28), a high-quality North American distributor of plumbing, HVAC, waterworks, and maintenance, repair, and operations (MRO) products to contractors, builders, and facility maintenance professionals.
-
Economics Weekly: What’s Up With the Housing Market
Given that housing is one of the most interest-rate-sensitive sectors of the economy, and with mortgage rates jumping from 3.0% to 7.2% today and affordability extremely low yet sales and starts jumping, in this Economics Weekly, we once again look at what’s happening with housing.
-
-
Bain Capital Tech Opportunities Has Led A Growth Investment in Blackpoint
William Blair acted as the exclusive financial advisor to Bain Capital Tech Opportunities in connection with a $190 million growth investment in Blackpoint Cyber (Blackpoint), with participation from Accel. Bain Capital Tech Opportunities and Accel join existing investors including Adelphi Capital Partners, Telecom Ventures, Pelican Ventures and WP Global Partners.
-
-
-
-
Economics Weekly: Two Major Market Concerns About the Fed’s Balance Sheet
In this Economics Weekly, we look at two areas of the Fed’s balance sheet that are on investors’ minds: 1) the ongoing quantitative tightening (QT) and the extent to which the Fed will actually be able to shrink the size of its balance sheet before running into market turmoil, and 2) the rebuilding of the Treasury General Account (TGA) and what happens with the infamous reverse repo account.
-
-
-
Economics Weekly: Macro Highlights From William Blair’s 43rd Annual Growth Stock Conference
In this Economics Weekly, we provide a smattering of quotes and commentary (with added emphasis) from what we were able to glean from each of the William Blair Growth Stock Conference presentations we attended.
-
-
-
William Blair Adds Two Senior Hires to Growing Private Capital Advisory Team
William Blair announced today the continued expansion of the firm’s Private Capital Advisory investment banking practice with the addition of two senior hires. Based in Charlotte and focused on fund placement in the Mid-Atlantic, Southeast, and South regions, Matthew Flynn joins as managing director and Hudson Collins joins as director in New York.
-
Rising Black Women Entrepreneurs Pitch Businesses During William Blair Event
William Blair was honored to host a dynamic group of Black women entrepreneurs, recent graduates of YWCA Metropolitan Chicago’s Breedlove business accelerator program, for a pitch demonstration of their companies to colleagues and guests.
-
William Blair Expands Private Wealth Teams in San Francisco, Denver
William Blair announced today the expansion of the firm’s Private Wealth Management offices in San Francisco and Denver. Laura Harrison Ward joins as managing director, wealth advisor in San Francisco, and Mark N. Warren and John D. Warren join as managing directors, wealth advisors in Denver.
-
William Blair and National Center for Family Philanthropy Partner for Talk on Today’s Trends in Charitable Giving
William Blair and the National Center for Family Philanthropy (NCFP) partnered to host a meaningful conversation on today’s trends in philanthropy with family foundations from the Denver community, exploring how they can make the greatest impact in a world that is rapidly changing.
-
-
William Blair Announces New “William Blair Thinking” Podcast Platform
William Blair today announced the launch of the William Blair Thinking podcast, a platform featuring conversations with individuals from the firm’s equity research and capital advisory groups, as well as industry professionals, academics, and more.
-
-
Qualys, Inc.: Initiation of Research Coverage
William Blair initiated research coverage of Qualys, Inc. (QLYS $126.80), a leading provider of cloud-based cybersecurity and compliance solutions that help companies identify security risks, maintain compliance with industry standards, and remediate security vulnerabilities.
-
Celebrating Asian/Pacific American Month With Cancer Research Charity Founder
Everyday hero and mother Kathy Liu celebrated Asian American and Pacific Islander Heritage Month with William Blair colleagues by sharing her story of resilience and determination that led to founding a 100% volunteer-led pediatric cancer research charity, Joey’s Wings Foundation, in memory of her son.
-
-
Vertex Pharmaceuticals Incorporated: Initiation of Research Coverage
William Blair initiated research coverage of Vertex Pharmaceuticals Incorporated (VRTX $332.63), a biopharma company focused on the development and commercialization of transformative specialty medicines for the treatment of cystic fibrosis (CF) and other rare genetic diseases.
-
-
-
Economics Weekly: What Past Easing Cycles Tell Us About the Future
In this Economics Weekly, we examine previous easing cycles—how long rates stay at their peak levels before easing starts, how large is the first cut, and how much do rates decline in 12 months and over the entire cycle—and whether we can draw any conclusions regarding the easing cycle we might be in for when the next one finally gets underway.
-
-
-
-
-